Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Prostatic Neoplasms 10Head and Neck Neoplasms 5Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Central Nervous System Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Oligodendroglioma 2Neurotoxicity Syndromes 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Fibrosarcoma 2Breast Neoplasms 2Astrocytoma 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Untreated Childhood Medulloblastoma 1Tongue Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1

Interventions

Doxorubicin 7Ifosfamide 6brostallicin 2Trabectedin 2Filgrastim 2perifosine 1pegfilgrastim 1lorvotuzumab mertansine 1indolepropanol phosphate 1exatecan 1X-Rays 1Watchful Waiting 1Radiotherapy, Conformal 1Radiotherapy 1Observation 1Mass Spectrometry 1Imatinib Mesylate 1Gefitinib 1Combined Modality Therapy 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1Biopsy 1BI 2536 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sarcoma, Synovial × Radiotherapy, Conformal × Clear all
NCT00346164 2022-04-28

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Children's Oncology Group

Phase 3 Completed
588 enrolled 22 charts
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡